These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6174603)

  • 21. T cell recognition of the immunodominant Sendai virus NP324-332/Kb epitope is focused on the center of the peptide.
    Cole GA; Hogg TL; Woodland DL
    J Immunol; 1995 Sep; 155(6):2841-8. PubMed ID: 7673700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene complementation in the T lymphocyte proliferative response to poly (Glu57Lys38Tyr5): evidence for effects of polymer handling and gene dosage.
    Schwartz RH; Merryman CF; Maurer PH
    J Immunol; 1979 Jul; 123(1):272-8. PubMed ID: 87475
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors.
    Christadoss P; Lennon VA; Krco CJ; David CS
    J Immunol; 1982 Mar; 128(3):1141-4. PubMed ID: 6799570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The origins of alloreactivity: differentiation of prekiller cells to viral infection results in alloreactive cytolytic T lymphocytes.
    Finberg R; Cantor H; Benacerraf B; Burakoff S
    J Immunol; 1980 Apr; 124(4):1858-60. PubMed ID: 6245130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 28. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qa-1-associated antigens. I. Generation of H-2-nonrestricted cytotoxic T lymphocytes specific for determinants of the Qa-1 region.
    Kastner DL; Rich RR; Shen FW
    J Immunol; 1979 Sep; 123(3):1232-8. PubMed ID: 89166
    [No Abstract]   [Full Text] [Related]  

  • 30. Specificity and regulation of cytotoxic T-lymphocyte responses analyzed with H-2 mutants.
    Melief CJ; Stukart MJ; de Waal LP; Kast WM; Melvold RW
    Transplant Proc; 1983 Dec; 15(4):2086-9. PubMed ID: 6324427
    [No Abstract]   [Full Text] [Related]  

  • 31. Generation of the alloreactive T cell repertoire: K region homology between H-2b T cell precursors and T cell maturation environment is required for the generation of the Kbm6-specific cytotoxic T cell repertoire.
    Gress RE; Hodes RJ
    J Immunol; 1984 May; 132(5):2226-31. PubMed ID: 6201535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.
    Finberg R; Mescher M; Burakoff SJ
    J Exp Med; 1978 Dec; 148(6):1620-7. PubMed ID: 214512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion of Sendai virus with the target cell membrane is required for T cell cytotoxicity.
    Gething M; Koszinowski U; Waterfield M
    Nature; 1978 Aug; 274(5672):689-91. PubMed ID: 209339
    [No Abstract]   [Full Text] [Related]  

  • 35. Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells.
    Dave VP; Allan JE; Slobod KS; Smith FS; Ryan KW; Takimoto T; Power UF; Portner A; Hurwitz JL
    Virology; 1994 Mar; 199(2):376-83. PubMed ID: 7510085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ir gene control of immune responses to insulins. II. Phenotypic differences in T cell activity among nonresponder strains of mice.
    Bucy RP; Kapp JA
    J Immunol; 1983 May; 130(5):2062-6. PubMed ID: 6187834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant.
    Rock KL; Fleischacker C; Gamble S
    J Immunol; 1993 Feb; 150(4):1244-52. PubMed ID: 8381832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutationally derived H-2 antigenic differences as defined by cytolytic T lymphocyte clones.
    Sherman LA
    J Immunol; 1981 Sep; 127(3):1259-60. PubMed ID: 6167625
    [No Abstract]   [Full Text] [Related]  

  • 40. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.